Latest news
Weekly Recap: Merger talks with Bristol Myers and Imjudo launch in China - TradingViewTradingView · Mon, 10 Aug 2026 05:15:00 GMTAstraZeneca-Bristol Myers’ $400B Merger Buzz Cools After Report Denies Talks – ‘There Never Was A Deal To Be Done’ - StocktwitsStocktwits · Sat, 08 Aug 2026 09:44:55 GMTBiotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure? - StocktwitsStocktwits · Sat, 08 Aug 2026 07:34:42 GMT$400B AstraZeneca-Bristol Myers Squibb merger rumor draws market reaction - AxiosAxios · Fri, 07 Aug 2026 21:39:29 GMTAstraZeneca, BMS not pursuing merger talks: Reuters - NJBIZNJBIZ · Thu, 06 Aug 2026 17:42:22 GMTWhat the AstraZeneca-BMS rumors reveal about pharma megamergers - Pharma VoicePharma Voice · Thu, 06 Aug 2026 13:40:22 GMTMergers as Strategic Architecture: Rethinking How to Evaluate the AstraZeneca–BMS Rumors - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 06 Aug 2026 10:02:44 GMTAstraZeneca may buck a decade of pharma strategy to buy U.S. scale - CNBCCNBC · Thu, 06 Aug 2026 09:40:16 GMT